A Study on Rejecting Non-Target and Misclassified Motions for Robust Tactile-Sensor-Based Prosthetic Hand Control

一项关于如何剔除非目标和错误分类运动以实现基于触觉传感器的鲁棒假肢手控制的研究

阅读:1

Abstract

Reliable motion classification is essential for practical prosthetic-hand control. Unintended activations caused by ambiguous motions, unknown motions, or non-target body movements can degrade controllability and compromise user safety. Mechanical-sensing approaches are attracting attention as alternatives or complements to surface electromyography, and tactile-sensor-based methods represent one such direction. However, despite extensive studies on prosthetic control, systematic investigations of computationally lightweight motion-rejection strategies remain limited. This study investigates rejection mechanisms to improve the robustness of polyvinylidene fluoride (PVDF) tactile-sensor-based prosthetic control. The proposed approach selectively withholds outputs for misclassified and non-target inputs. We compare three mechanisms: (1) one-class support vector machine (OCSVM) outlier detection, (2) entropy-based rejection using a multilayer perceptron (BPNN-Entropy), and (3) a parameter-free decision-consistency check for one-vs-rest support vector machines (SVMs) that withholds classification when the output sign pattern is inconsistent (one-vs-rest reject option (OvR-RO); proposed). Performance is evaluated for three sources of unintended activation: ambiguous target trials (retrospectively defined), unknown motions excluded from training, and non-target body movements. The results show that OvR-RO achieves a favorable balance between rejection rate and rejection precision for ambiguous motions, while maintaining responsiveness. Overall, explicitly rejecting misclassified and non-target motions is effective for enhancing robustness in tactile-sensor-based prosthetic control.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。